Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Potential Deal Alert: Rain Oncology (RAIN) approached by Concentra for $1.25 per share

  • October 15, 2023

According to an amended 13D filing, Rain Oncology (RAIN)  received an acquisition proposal from Concentra Biosciences, an affiliate of Tang Capital Partners, for $1.25 per share in cash.

Rain Oncology Investor Relations